| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/05/2007 | WO2007053447A3 Compositions and methods for the treatment and prevention of fibrotic, inflammatory and neovascularization conditions |
| 07/05/2007 | WO2007049805A8 Synthetic lipopeptide and use thereof for medical purposes |
| 07/05/2007 | WO2007048077A3 Antibodies with enhanced antibody-dependent cellular cytoxicity activity, methods of their production and use |
| 07/05/2007 | WO2007041564A3 (s)-6-methyloxaalkyl exemestane compounds and related methods of use |
| 07/05/2007 | WO2007039256A3 Binding domains of proteins of the repulsive guidance molecule (rgm) protein family and functional fragments thereof, and their use |
| 07/05/2007 | WO2007023386A3 Zwitterionization of capsular saccharides |
| 07/05/2007 | WO2007015935A8 Diagnostic methods for the prediction of therapeutic success, recurrence free and overall survival in cancer therapy |
| 07/05/2007 | WO2006088478A3 Methods and reagents for diagnosing hantavirus infection |
| 07/05/2007 | WO2006086288A3 Methods for reducing the symptoms of autoimmunity and inflammation using binding proteins against antigens exposed on dead or dying cells |
| 07/05/2007 | WO2006056779A3 ANTI-TNF ALPHA ANTIBODIES WHICH SELECTIVELY INHIBIT TNF ALPHA SIGNALLING THROUGH THE p55R |
| 07/05/2007 | WO2006033669A3 Method of modulating vascularization |
| 07/05/2007 | WO2006021210A3 Binding member towards pneumolysin |
| 07/05/2007 | WO2006017763A3 Capture and removal of biomolecules from body fluids using partial molecular imprints |
| 07/05/2007 | WO2005060377A3 Modulation of immunostimulatory properties by small oligonucleotide-based compounds |
| 07/05/2007 | WO2005023992A3 Compositions and methods for inhibiting white spot syndrome virus (wssv) infection |
| 07/05/2007 | WO2004083381A3 Fibroblast growth factor receptor-1 polynucleotides, polypeptides, and mutants |
| 07/05/2007 | WO2004069183A3 Immune regulation based on the targeting of early activation molecules |
| 07/05/2007 | WO2003066821A3 Molecules interacting with casl (mical) polynucleotides, polypeptides, and methods of using the same |
| 07/05/2007 | US20070157326 Ee3-protein family and corresponding dna sequence |
| 07/05/2007 | US20070156232 Medical Device with Coating that Promotes Endothelial Cell Adherence |
| 07/05/2007 | US20070155959 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 07/05/2007 | US20070155662 Diagnostics and therapeutics for diseases associated with phosphodiesterase 1a (pde1a) |
| 07/05/2007 | US20070154995 Development of human monoclonal antibodies and uses thereof |
| 07/05/2007 | US20070154986 Streptococcus pneumoniae Polynucleotides and Sequences |
| 07/05/2007 | US20070154953 Identification of antigen epitopes |
| 07/05/2007 | US20070154943 Methods for preventing cattle reproductive diseases |
| 07/05/2007 | US20070154902 Papilloma virus vaccine |
| 07/05/2007 | US20070154552 Biologically active native biomatrix composition |
| 07/05/2007 | US20070154496 Lolium perenne (Lol p 1) polypeptide for use as diagnostic/prognostic indicator or allergic reactions |
| 07/05/2007 | US20070154495 Modified whole cell, cell extract and omv-based vaccines |
| 07/05/2007 | US20070154494 Anthrax vaccines and delivery methods |
| 07/05/2007 | US20070154493 Method of treating skin needing botulinum toxin type a treatment |
| 07/05/2007 | US20070154492 Method for Purifying Polysaccharides |
| 07/05/2007 | US20070154491 Edible vaccine |
| 07/05/2007 | US20070154490 Sequence Of Reverse Transcriptase Gene And Method Of Use |
| 07/05/2007 | US20070154489 Infectious bronchitis virus with an altered spike gene |
| 07/05/2007 | US20070154488 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/05/2007 | US20070154487 Compositions and methods for modulation of RORgammat functions |
| 07/05/2007 | US20070154486 Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin |
| 07/05/2007 | US20070154485 Anticancer agents using verotoxin variants |
| 07/05/2007 | US20070154484 Oral use of specific antibodies for intestinal health |
| 07/05/2007 | US20070154483 Treatment with anti-vegf antibodies |
| 07/05/2007 | US20070154482 Methods and compositions for the treatment and diagnosis of diseases characterized by vascular leak, hypotension, or a procoagulant state |
| 07/05/2007 | US20070154481 Antibody Molecules Having Specificity For Human IL-6 |
| 07/05/2007 | US20070154480 for treatment of diseases associated with amyloid deposits of A beta in the brain such as Alzheimer's disease |
| 07/05/2007 | US20070154479 Effect of Bst2 on inflammation |
| 07/05/2007 | US20070154478 Therapeutic composition |
| 07/05/2007 | US20070154477 Humanized anti-CD3 specific antibodies |
| 07/05/2007 | US20070154476 Receptor coupling agents and therapeutic uses thereof |
| 07/05/2007 | US20070154475 Novel polypeptides having sequence similarity to GDNFR and nucleic acids encoding the same |
| 07/05/2007 | US20070154474 Human Prostate Specific G-Protein Receptor HPRAJ70 |
| 07/05/2007 | US20070154473 Anti-CD19 antibodies with reduced immunogenicity |
| 07/05/2007 | US20070154472 Sulfotyrosine specific antibodies and uses therefor |
| 07/05/2007 | US20070154471 separating an F(ab')2 fragment from a non-F(ab')2 portion of an antibody (immunoglobulin) by limited thermolysin digestion of theantibodies |
| 07/05/2007 | US20070154470 Holt's O(log N) method to search a massively poly-clonal collection of hybridomas to detect, select and isolate target-antigen-specific high-affinity monoclonal-antibody-generating hybridomas for the rapid development and manufacture of highly specific and effectively targeted monoclonal antibodies |
| 07/05/2007 | US20070154469 IGM production by transformed cells and methods of quantifying said IgM production |
| 07/05/2007 | US20070154468 Use of CD28-specific monoclonal antibodies for producing a pharmaceutical composition for treating virus infections |
| 07/05/2007 | US20070154464 Methods for screening for agents capable of modulating t lymphocyte function in response to a herpes simplex virus-infected cell |
| 07/05/2007 | US20070154455 Monoparamunity inducers based on attenuated rabbit myxoma viruses |
| 07/05/2007 | US20070154454 Compositions and methods for treating poxvirus infection |
| 07/05/2007 | US20070154450 Blocking leukocyte emigration and inflammation by interfering with cd99/hec2 |
| 07/05/2007 | US20070154446 A polypeptide covalently attached with a polyethylene glycol propionaldehyde group having anti-hepatitis C activity |
| 07/05/2007 | US20070154391 Monoclonal antibodies; hybridomas; competitive binding |
| 07/05/2007 | CA2635692A1 Human anti-il-23 antibodies, compositions, methods and uses |
| 07/05/2007 | CA2635598A1 Multivalent pcv2 immunogenic compositions and methods of producing such compositions |
| 07/05/2007 | CA2634955A1 Hypoallergenic variants of the major allergen from betula verrucosa pollen |
| 07/05/2007 | CA2634755A1 De-n-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy |
| 07/05/2007 | CA2634591A1 Method for detection of cancer cells using virus |
| 07/05/2007 | CA2634480A1 Immunogenic polypeptide composed of tumor antigen-derived optimized cryptic peptides, and uses thereof |
| 07/05/2007 | CA2634217A1 Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof |
| 07/05/2007 | CA2633486A1 Multivalent immunoglobulin-based bioactive assemblies |
| 07/05/2007 | CA2633424A1 Pharmaceutical compositions containing protein nma0939 |
| 07/05/2007 | CA2632799A1 Tgf-beta binding compositions |
| 07/05/2007 | CA2632698A1 Methods of using cd40 binding agents |
| 07/05/2007 | CA2631212A1 Antagonists of hmgb1 and/or rage and methods of use thereof |
| 07/04/2007 | EP1804062A2 YKL-40 as a marker and prognostic indicator for cancers |
| 07/04/2007 | EP1803807A2 Virulence genes, proteins, and their use |
| 07/04/2007 | EP1803731A1 Method of producing partial peptide of enolase protein from plasmodium falciparum |
| 07/04/2007 | EP1803730A1 Albumin fusion proteins |
| 07/04/2007 | EP1803466A1 Treatment of chronic joint inflammation by an anti-CD3 antibody |
| 07/04/2007 | EP1802746A2 Virosome particles comprising antigens from influenza virus and hepatitis b virus |
| 07/04/2007 | EP1802659A2 Compositions and methods for treatment of non-hodgkin's lymphoma |
| 07/04/2007 | EP1802656A1 Tweak receptor |
| 07/04/2007 | EP1802645A2 Recombinant bifunctional protein of human lutropin receptor and human chorionic gonadotropin b-subunit and uses thereof |
| 07/04/2007 | EP1802346A1 Sustained release pharmaceutical composition |
| 07/04/2007 | EP1802345A2 Methods of treating cd30 positive lymphomas |
| 07/04/2007 | EP1802344A2 Antibody formulation in histidine-acetate buffer |
| 07/04/2007 | EP1802343A2 E2-epf5, a novel therapeutic protein and target |
| 07/04/2007 | EP1802342A1 Immunoadsorber for treating inflammations |
| 07/04/2007 | EP1802341A1 Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody |
| 07/04/2007 | EP1802340A1 Combination of a recombinant mycobacterium and a biologically active agent as a vaccine |
| 07/04/2007 | EP1802339A2 Treating neoplasms with neurotoxin |
| 07/04/2007 | EP1802338A2 High cell density process for growth of listeria |
| 07/04/2007 | EP1802337A2 Consortium of nitrifying bacteria |
| 07/04/2007 | EP1802336A1 Malaria prime/boost vaccines |
| 07/04/2007 | EP1802335A2 Immunogenic compositions of staphylococcus epidermidis polypeptide and polynucleotide antigens |
| 07/04/2007 | EP1802334A1 Method for treating intraocular neovascular diseases |
| 07/04/2007 | EP1802333A2 Antibody buffering of a ligand in vivo |
| 07/04/2007 | EP1802332A2 Modified hiv-1 envelope proteins |
| 07/04/2007 | EP1802330A2 Validation of tssk family members and tsks as male contraceptive targets |